← Back to Search

Comparing CBT-T to CBT-E in Non-low-weight Adults With Eating Disorders

N/A

Waitlist Available

Led By Elizabeth Phoenix

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two types of cognitive behavioural therapy for people with eating disorders who are not underweight. The goal is to see which therapy is more effective and has less drop-out.

Eligible Conditions

Anorexia nervosa

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Eating Disorder Cognitions

Change in the frequency of Binge Eating

Change in the frequency of Vomiting

Secondary study objectives

Binge Eating Change over the Course of Treatment

Change in Depression symptoms

Change in Impulsivity

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CBT-TExperimental Treatment1 Intervention

Participants will be randomly assigned to one of two conditions (CBT-E or CBT-T). Participants who agree to participate will receive 10 weeks of CBT-T.

Group II: CBT-EActive Control1 Intervention

Participants will be randomly assigned to one of two conditions (CBT-E or CBT-T). CBT-E will occur over the course of 25 weeks and be delivered as it typically is in the clinic setting of the investigators.

Do I qualify?Apply below to find out